Medications

Novel agent promising for the treatment of schizophrenia

(HealthDay)—For patients with an acute exacerbation of schizophrenia, SEP-363856, a non-D2-receptor-binding drug that has agonist activity at trace amine-associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A receptors, ...

Surgery

Less pain post TKA with addition of peripheral nerve blocks

(HealthDay)—Addition of an interspace between the popliteal artery and capsule of the posterior knee (IPACK) block and adductor canal block (ACB) to periarticular injection (PAI) is associated with less pain after total ...

page 2 from 5